Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Sonus and Daiichi terminate licensing agreement

Dec. 2, 1998

AngioMARK significantly improves imaging of vascular structures in phase II trial

Dec. 1, 1998

Nycomed Amersham submits MAA for Diatide's NeoTect to EMEA

Nov. 25, 1998

New MRI contrast agents with favorable neurotoxicity profile developed at Bracco

Nov. 23, 1998

Contrast sonography with Echovist is safe and effective for assessing tubal patency

Nov. 19, 1998

New oral ultrasound contrast agent approved by FDA

Nov. 17, 1998

FDA grants priority review status to Zila's NDA for OraTest

Nov. 12, 1998

CEA-Scan accurately detects breast cancer with low rate of false-positive results

Oct. 29, 1998

FDA clears first test for CMV DNA

Oct. 29, 1998

Launch of Innotest Beta-Amyloid(1-42) test enables more reliable diagnosis of AD

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...